1. Home
  2. KALA vs JZ Comparison

KALA vs JZ Comparison

Compare KALA & JZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KALA
  • JZ
  • Stock Information
  • Founded
  • KALA 2009
  • JZ 2011
  • Country
  • KALA United States
  • JZ China
  • Employees
  • KALA N/A
  • JZ N/A
  • Industry
  • KALA Biotechnology: Pharmaceutical Preparations
  • JZ Other Consumer Services
  • Sector
  • KALA Health Care
  • JZ Real Estate
  • Exchange
  • KALA Nasdaq
  • JZ Nasdaq
  • Market Cap
  • KALA 26.2M
  • JZ 26.7M
  • IPO Year
  • KALA 2017
  • JZ 2022
  • Fundamental
  • Price
  • KALA $4.03
  • JZ $1.92
  • Analyst Decision
  • KALA Strong Buy
  • JZ
  • Analyst Count
  • KALA 3
  • JZ 0
  • Target Price
  • KALA $14.00
  • JZ N/A
  • AVG Volume (30 Days)
  • KALA 38.5K
  • JZ 228.7K
  • Earning Date
  • KALA 08-05-2025
  • JZ 01-01-0001
  • Dividend Yield
  • KALA N/A
  • JZ N/A
  • EPS Growth
  • KALA N/A
  • JZ N/A
  • EPS
  • KALA N/A
  • JZ N/A
  • Revenue
  • KALA N/A
  • JZ $34,090,704.00
  • Revenue This Year
  • KALA N/A
  • JZ N/A
  • Revenue Next Year
  • KALA N/A
  • JZ N/A
  • P/E Ratio
  • KALA N/A
  • JZ N/A
  • Revenue Growth
  • KALA N/A
  • JZ N/A
  • 52 Week Low
  • KALA $2.92
  • JZ $1.72
  • 52 Week High
  • KALA $11.20
  • JZ $14.60
  • Technical
  • Relative Strength Index (RSI)
  • KALA 53.41
  • JZ 23.28
  • Support Level
  • KALA $4.10
  • JZ $1.72
  • Resistance Level
  • KALA $4.41
  • JZ $3.03
  • Average True Range (ATR)
  • KALA 0.39
  • JZ 0.48
  • MACD
  • KALA 0.01
  • JZ -0.07
  • Stochastic Oscillator
  • KALA 52.39
  • JZ 6.04

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

About JZ Jianzhi Education Technology Group Company Limited

Jianzhi Education Technology Group Co Ltd engages in developing educational content to fulfill the massive demand for high-quality, professional development training resources in China. The company and its subsidiaries VIE and VIEs generate subscription revenue through selling subscriptions to online learning platforms, higher education institutions, and other institutional customers under a B2B2C model mainly through the platform of Sentu Academy; offering subscriptions concerning educational content in mobile video packages directly to end users under a B2C model through the platforms such as Fish Learning or Light Class, etc. It has two operating segments: Educational content services and other services and IT-related solution services.

Share on Social Networks: